AVID BIOSERVICES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.44 USD | -0.67% |
|
-6.88% | +14.46% |
| 04-30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
| 04-29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVID BIOSERVICES, INC. | Biopharmaceuticals | -0.67% | -6.88% | +14.46% | -53.59% | +90.28% | 475M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- CDMO Stock
- Charts Avid Bioservices, Inc.
- Comparison Chart